Brief: Geovax's Next-Generation Covid-19 Vaccine Shows High Immunogenicity In Immunocompromised Patients

Geovax Labs

24/05/2023 13:21

May 24 (Reuters) - GeoVax Labs Inc  GOVX.O :
    * GEOVAX’S NEXT-GENERATION COVID-19 VACCINE SHOWS HIGH
IMMUNOGENICITY IN IMMUNOCOMPROMISED PATIENTS

Source text for Eikon:  ID:nGNX8MMfcy 
Further company coverage:  GOVX.O 

 ((reuters.briefs@thomsonreuters.com;))